LIABILITIES
Perjanjian dan Komitmen Agreements and Commitments a. Perjanjian Manufaktur a. Manufacturing Agreements Dalam aktivitas bisnisnya, Perusahaan
mengadakan perjanjian dengan pihak ketiga untuk memproduksi obat Perusahaan (toll-out).
Selain itu, Perusahaan mengadakan perjanjian dengan pihak ketiga untuk memproduksi obat pihak ketiga (toll-in). Biaya terkait aktivitas toll-out dan imbalan jasa terkait aktivitas toll-in, termasuk produk yang diproduksi diatur secara spesifik dalam perjanjian.
Perjanjian-perjanjian tersebut memiliki jangka waktu yang bervariasi antara 1 (satu) dan 2 (dua) tahun serta memiliki klausul pembaruan secara otomatis.
In doing its business activities, the Company has entered into an agreement with third parties to produce its products (toll-out).
In addition to that, the Company has entered into an agreement with third parties to produce third parties’ products. Costs related to the toll-out activities and fees related to the toll-in activities, including products to be manufactured, are specified in each agreement.
These agreements have various durations between 1 (one) and 2 (two) years and have automatic renewal clauses.
Berikut ini pihak ketiga dimana Perusahaan melakukan perjanjian manufaktur obat:
Pihak ketiga/ Third parties PT Ethica Industri Farmasi PT Actavis Indonesia PT Meprofarm
PT Dipa Pharmalab Intersains PT Erlimpex
PT Futamed
PT Guardian Pharmatama PT Hexpharm Jaya Laboratories PT Ikapharmindo
PT Interbat
PT Mahakam Beta Farma PT Metiska
PT Nufarindo
PT Oryza Farma Indonesia PT Otto Pharmaceutical PT Pertiwi Agung PT Pfizer Indonesia Tbk PT Pharos
PT Pyridam Farma PT Soho Global Health PT Bernofarm
PT Coronet Crown Pharmaceutical Industries PT Dankos Farma
Following are the third parties of which the Company has manufacturing agreements with:
Jenis perjanjian/ Type of agreements Toll-in
36. PERJANJIAN, KOMITMEN, DAN LIABILITAS
KONTIJENSI YANG SIGNIFIKAN (Lanjutan) 36. SIGNIFICANT AGREEMENTS, COMMITMENTS AND CONTIGENCIES LIABILITIES (Continued)
Perjanjian dan Komitmen (Lanjutan) Agreements and Commitments (Continued) a. Perjanjian Manufaktur (Lanjutan) a. Manufacturing Agreements
(Continued) Pihak ketiga/ Third parties (Lanjutan)
PT Dankos Farma PT Darya Varia PT Djago
PT Promedraharjo PT Nulab Pharmaeutical PT Gracia Pharmindo PT Asuransi Jiwa Health PT B.Braun Medical indonesia Equilab International
Jenis perjanjian/ Type of agreements (Continued)
Toll-in, toll out.
Toll-out Toll-out Toll-in
Pembuatan Produk Toll in
Perjanjian Penyediaan Obat Izin Edar
Penelitian
Pihak berelasi/ Related parties PT Kimia Farma Tbk
PT Indofarma (Persero)Tbk PT Lucas Djaja
PT Marin Liza Farmasi
PT Kimia Farma Trading Distribution PT Rajawali nusindo
Jumlah pendapatan terkait dengan aktivitas toll manufacturing adalah sebesar Rp15.103.448.954 pada 30 September 2021
dan Rp17.472.874.548 pada
30 September 2020.
Jenis perjanjian/ Type of agreement Toll-out
Toll-in, toll-out Toll-in
Toll-out Distribusi Distribusi
Total revenues related to toll manufacturing activities were Rp15.103.448.954 for period ended September 30, 2021 and Rp17.472.874.548 for period ended September 30, 2020.
36. PERJANJIAN, KOMITMEN, DAN LIABILITAS KONTIJENSI YANG SIGNIFIKAN (Lanjutan)
36. SIGNIFICANT AGREEMENTS, COMMITMENTS AND CONTIGENCIES LIABILITIES (Continued)
b. Perjanjian distribusi
Pada tanggal 20 Januari 1992, Perusahaan mengadakan perjanjian distribusi dengan PT Rajawali Nusindo, pihak berelasi (“Distributor”), di mana Perusahaan menunjuk PT Rajawali Nusindo sebagai distributor utama produk Perusahaan.
Perjanjian ini telah diperpanjang beberapa kali; terakhir pada tanggal
28 Desember 2020, yang
memperpanjang masa berlaku kerjasama untuk produk non-irisan hingga 31 Desember 2021 serta irisan dan e-catalogue hingga 31 Desember 2022.
Distributor wajib membayar Perusahaan sebesar harga yang yang telah disepakati dalam perjanjian yang berlaku, terhitung sejak produk diterima di gudang cabang Distributor. Distributor berhak mendapatkan margin distribusi yang besarannya ditentukan dalam perjanjian.
b Distribution agreement
On January 20, 1992, the Company entered into a distribution agreement with PT Rajawali Nusindo, related party (“Distributor”), of which the Company appointed PT Rajawali Nusindo as the sole distributor of the Company’s products.
This agreement was extended several times; the latest was on Desember 28, 2020, which was extended for non slice product to December 31, 2021 and for slice and e-catalogue product to December 31, 2022.
The distributor must pay the Company the price as agreed in the valid agreement when the product is received in the Distributor’s warehouse. The Distributor is entitled for a distribution margin whose amount was agreed in the agreement.
Apabila Distributor terlambat melakukan pembayaran dengan batas maksimum keterlambatan selama 45 (empat puluh lima) hari. Distributor akan dikenakan denda sebesar suku bunga pinjaman komersial yang berlaku dari harga produk yang belum dibayar. Apabila keterlambatan telah melebihi batas maksimum tersebut, Perusahaan berhak menetapkan denda di luar bunga pinjaman komersial.
If the Distributor made late payments with a maximum of 45 (forty-five)-day late. The Distributor will be imposed a penalty as much as applicable commercial interest rate of the product price which has not been paid.
If the late period has exceeded that maximum limit, the Company has the right to impose sanctions outside the commercial interests.
36. PERJANJIAN, KOMITMEN, DAN LIABILITAS
KONTIJENSI YANG SIGNIFIKAN (Lanjutan) 36. SIGNIFICANT AGREEMENTS, COMMITMENTS AND CONTIGENCIES LIABILITIES (Continued)
Perjanjian dan Komitmen (Lanjutan) Agreements and Commitments (Continued) b. Perjanjian distribusi (Lanjutan) b. Distribution agreement (Continued)
Jumlah pendapatan sampai dengan 30 September 2021 terkait dengan perjanjian distribusi ini adalah Rp362.348.538 dan 30 September 2020 sebesar Rp486.881.556. Jumlah pendapatan bersih dari denda keterlambatan pembayaran sampai dengan 30 September 2021 dan 2020 adalah nihil.
Pada tanggal 14 Mei 2019, Perusahaan telah mengadakan perjanjian distribusi dengan Kimia Farma Trading &
Distribution dengan perjanjian No.
018/S.Pj/LE/V/19 dengan jangka waktu dimulai per 1 Juni 2019 yang telah dilakukan beberapa kali perubahan, dan terakhir pada 4 Januari 2021 untuk jangka waktu selama 2 (dua) tahun sampai dengan 31 Desember 2022.
Jumlah pendapatan untuk periode 30 September 2021 terkait dengan perjanjian distribusi ini adalah Rp1.052.585.894 dan periode 30 September 2020 sebesar Rp.774.235.655.
Total revenues up to September 30, 2021 related to the distribution agreement were Rp362,348,538 and September 30, 2020 amounted of Rp486,881,556. The net revenues from penalty receivables in until on September 30, 2021 and September 30, 2020 were nil.
On May 14, 2019 the Company has entered into a distribution agreement with Kimia Farma Trading & Distribution under agreement No. 018/S.Pj/LE/V/19 with a period starting from June 1, 2019 which been amended several times, the latest was on January 4, 2021 for a period of 2 (two) years until December 31, 2022.
Total revenues for the period ended September 30, 2021 related to the distribution agreement were Rp325,969,774 and September 30, 2020 amounted to Rp241,409,429.
c. Perjanjian pemasaran dan distribusi c. Marketing and distribution agreement Pada tanggal 20 November 2019,
Perusahaan mengadakan Perjanjian dengan PT Swayasa Perkasa No. 080/S.Pj/LE/XI/19 dan No. 033/Kontrak/SP-Phapros/XI/2019 dengan jangka waktu 5 (lima) tahun untuk produk sesuai kesepakatan.
On November 20, 2019, the Company has entered into distribution agreement with PT Swayasa Perkasa No. 080/S.Pj/LE/XI/19 and No. 033/Kontrak/SP-Phapros/XI/2019 with 5 (five) years period for agreed product.
Jumlah pendapatan sampai dengan periode 30 September 2021 yang sehubungan dengan kerjasama tersebut adalah Rp2.146.052 dan sampai dengan periode 30 September 2020 sebesar Rp1.094.275.
As of September 30, 2021, total income related to the cooperation were Rp2.146.052 and As of September 30, 2020 amounted to Rp1.094.275.
36. PERJANJIAN, KOMITMEN, DAN LIABILITAS KONTIJENSI YANG SIGNIFIKAN (Lanjutan)
36. SIGNIFICANT AGREEMENTS,
COMMITMENTS AND CONTIGENCIES